Advertisement
UK markets close in 3 hours 7 minutes

  • FTSE 100

    8,089.49
    +44.68 (+0.56%)
     

  • FTSE 250

    19,794.57
    -5.15 (-0.03%)
     

  • AIM

    755.24
    +0.37 (+0.05%)
     

  • GBP/EUR

    1.1637
    +0.0009 (+0.08%)
     

  • GBP/USD

    1.2438
    -0.0015 (-0.12%)
     

  • Bitcoin GBP

    53,629.21
    +520.83 (+0.98%)
     

  • CMC Crypto 200

    1,438.89
    +14.79 (+1.04%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CRUDE OIL

    82.97
    -0.39 (-0.47%)
     

  • GOLD FUTURES

    2,325.30
    -16.80 (-0.72%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • DAX

    18,185.47
    +47.82 (+0.26%)
     

  • CAC 40

    8,144.59
    +38.81 (+0.48%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

BioNTech stock slumps on worse-than-expected drop in revenue

Yahoo Finance

Yahoo Finance Live’s Julie Hyman breaks down the decline in stock for BioNTech.

Video transcript

JULIE HYMAN: A trending ticker you should keep an eye on, shares of Germany's BioNTech slumping as it forecast a worse-than-expected drop in its revenue this year amid drying-up demand for COVID vaccines. The group partnered up with Pfizer, remember, for its pandemic shot, but it's now warning revenue from COVID vaccines could drop to around 5 billion euros in 2023. The shares are down 4%.

We'll be right back.